Top Markets
Coin of the day
GeneDx Holdings Corp. GeneDx Holdings Corp.

GeneDx Holdings Corp.

WGS
Rang in aandelen #5446
GeneDx Holdings Corp. functions as a health intelligence firm singularly... GeneDx Holdings Corp. functions as a health intelligence firm singularly focused on the individual patient. It aims to revolutionize healthcare delivery by deploying advanced artificial intelligence and machine learning capabilities. These sophisticated algorithms are applied to vast, longitudinal clinical and genomic datasets to construct comprehensive, dynamic models of human health, ultimately defining personalized, optimal pathways for each person's well-being. Through its exclusive Centrellis health intelligence platform, the company gains profound insights into both disease states and overall wellness, enabling it to furnish evidence-based solutions for the most critical medical challenges. Eric Schadt established the corporation in October 2015, and its principal offices are located in Stamford, Connecticut.
Aandeelprijs
$90.29
Laatst gesynchroniseerd: 2026-08-26
Marktkapitalisatie
$2.69B
Verandering (1 dag)
3.30%
Verandering (1 jaar)
-30.11%
Land
US
Handel GeneDx Holdings Corp. (WGS)

Categorie

Aandelsplitsingen voor GeneDx Holdings Corp. (WGS)
Het aandeel GeneDx Holdings Corp. (symbool: WGS) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 27, 2026.
Eén aandeel WGS dat vóór Aug 27, 2026 werd gekocht, staat nu gelijk aan 0 aandelen WGS.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten